Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer

被引:122
作者
Chen, Z-Y [1 ]
Raghav, K. [2 ]
Lieu, C. H. [3 ]
Jiang, Z-Q [2 ]
Eng, C. [2 ]
Vauthey, J-N [4 ]
Chang, G. J. [4 ]
Qiao, W. [5 ]
Morris, J. [5 ]
Hong, D. [6 ]
Hoff, P. [7 ]
Tran, H. [8 ]
Menter, D. G. [2 ]
Heymach, J. [8 ]
Overman, M. [2 ]
Kopetz, S. [2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[3] Univ Colorado, Div Med Oncol, Aurora, CO USA
[4] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[5] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[6] Univ Texas Houston, MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[7] Univ Sao Paulo, Fac Med, Oncol Clin, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[8] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
angiogenesis; cytokine; growth factors; inflammation; metastatic colorectal cancer; neutrophil-lymphocyte ratio; survival; CHRONIC INFLAMMATION; COLON-CANCER; GENETIC INSTABILITY; POOR-PROGNOSIS; SOLID TUMORS; BIOMARKERS; BEVACIZUMAB; RESISTANCE; CARCINOMA; THERAPY;
D O I
10.1038/bjc.2015.61
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High circulating neutrophil-lymphocyte ratio (NLR) appears to be prognostic in metastatic colorectal cancer (mCRC). We investigated the relationship of NLR with circulating cytokines and molecular alterations. Methods: We performed retrospective analyses on multiple cohorts of CRC patients (metastatic untreated (n = 166), refractory metastatic (n = 161), hepatectomy (n = 198), stage 2/3 (n = 274), and molecularly screened (n = 342)). High NLR (ratio of absolute neutrophil-to-lymphocyte counts in peripheral blood) was defined as NLR>5. Plasma cytokines were evaluated using multiplex-bead assays. Kaplan-Meier estimates, non-parametric correlation analysis, and hierarchical cluster analyses were used. Results: High NLR was associated with poor prognosis in mCRC (hazard ratio (HR) 1.73; 95% confidence interval (CI): 1.03-2.89; P = 0.039) independent of known prognostic factors and molecular alterations (KRAS/NRAS/BRAF/PIK3CA/CIMP). High NLR correlated with increased expression of interleukin 6 (IL-6), IL-8, IL-2R alpha, hepatocyte growth factor, macrophage-colony stimulating factor, and vascular epidermal growth factor in exploratory (n = 39) and validation (n = 166) cohorts. Fourteen additional cytokines correlated with high NLR in the validation cohort. All 20 cytokines fell into three major clusters: inflammatory cytokines, angiogenic cytokines, and epidermal growth factor ligands. In mCRC, composite stratification based on NLR-cytokine score provided enhanced prognostic information (HR 2.09; 95% CI: 1.59-2.76; P<0.001) over and above NLR. Conclusions: High NLR is an independent poor prognostic marker in CRC and correlates with a distinct cytokine profile related to key biological processes involved in carcinogenesis. A composite NLR-cytokine stratification has enhanced prognostic value in mCRC.
引用
收藏
页码:1088 / 1097
页数:10
相关论文
共 48 条
  • [1] Absenger G, 2013, ANTICANCER RES, V33, P4591
  • [2] Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
    Bandapalli, Obul R.
    Ehrmann, Franziska
    Ehemann, Volker
    Gaida, Matthias
    Macher-Goeppinger, Stephan
    Wente, Moritz
    Schirmacher, Peter
    Brand, Karsten
    [J]. CYTOKINE, 2012, 57 (01) : 46 - 53
  • [3] Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
    Bisgin, Atil
    Kargi, Aysegul
    Yalcin, Arzu D.
    Aydin, Cigdem
    Ekinci, Deniz
    Savas, Burhan
    Sanlioglu, Salih
    [J]. BMC CANCER, 2012, 12
  • [4] Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
    Colotta, Francesco
    Allavena, Paola
    Sica, Antonio
    Garlanda, Cecilia
    Mantovani, Alberto
    [J]. CARCINOGENESIS, 2009, 30 (07) : 1073 - 1081
  • [5] Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
    Coussens, Lisa M.
    Zitvogel, Laurence
    Palucka, A. Karolina
    [J]. SCIENCE, 2013, 339 (6117) : 286 - 291
  • [6] Cancer-related inflammation and treatment effectiveness
    Diakos, Connie I.
    Charles, Kellie A.
    McMillan, Donald C.
    Clarke, Stephen J.
    [J]. LANCET ONCOLOGY, 2014, 15 (11) : E493 - E503
  • [7] ULCERATIVE-COLITIS AND COLORECTAL-CANCER - A POPULATION-BASED STUDY
    EKBOM, A
    HELMICK, C
    ZACK, M
    ADAMI, HO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) : 1228 - 1233
  • [8] Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO
  • [9] 2-J
  • [10] Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
    Erreni, Marco
    Mantovani, Alberto
    Allavena, Paola
    [J]. CANCER MICROENVIRONMENT, 2011, 4 (02) : 141 - 154